Bimekizumab Effective for Patients With Moderate to Severe HS ...Middle East

Medscape - News
Data from two phase 3 studies "support the use of bimekizumab as a promising new therapeutic option for patients with moderate to severe hidradenitis suppurativa," the authors concluded. Medscape Medical News

Hence then, the article about bimekizumab effective for patients with moderate to severe hs was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bimekizumab Effective for Patients With Moderate to Severe HS )

Apple Storegoogle play

Last updated :

Also on site :



Latest News